The lamina intima of an artery is the region between the endothelial cell surface and the internal elastic lamina, which forms the luminal margin of the media. In humans the intima of atherosclerosis-prone arteries becomes thicker due to accumulation of smooth muscle cells, which originate from the media. The introduction of percutaneous transluminal coronary angioplasty (PTCA) boosted scientific interest in intimal thickening, because restenosis remains an unresolved problem of this intervention. In order to unravel the mechanisms of intimal thickening there is a need for appropriate animal models. A brief overview of these models is given together with factors that control proliferation and/or migration.
Introduction
Neointima formation is a characteristic response of arteries to several forms of injury. As such it is one of the processes that contribute to the development of restenosis after a successful balloon angioplasty of a primary stenosis. In the following paragraphs, the general definitions. the animal models employed to study the development of a neointima and the concepts that arose from those studies are briefly given. The formation of a neointima in response to the mild damage created by repeated passage of an embolectomy catheter through the lumen of the rat arteria carotis communis is among the best studied in vivo models in vascular biology. Various drugs retarded intimal growth in this rat model, but unfortunately not one of them decreased the frequency of restenosis after percutaneous trans luminal coronary angioplasty (PTCA) in clinical trials. The final sections are therefore devoted to discussing the factors that could possibly contribute to these disappointing discrepancies between this animal model of neointima formation and an important clinical problem.
Definitions of intima and neointima
The lamina intima of an artery is defined as the region between the endothelial cell surface and the internal elastic lamina. which forms the luminal margin of the media. I In humans. the intima of the aorta and atherosclerosis-prone arteries becomes thicker due to accumulation of smooth muscle cells, which originate from the media. The intimal thickening that forms in response to injury of arteries of rodents and rabbits is often called a neointima because the original intima is destroyed in most models and did not contain smooth muscle cells or cell types other than endothelial cells.
Physiological intimal thickening At birth, the intima of human arteries consists solely of endothelial cells, which rest directly on the internal elastic lamina. Early in life. however, smooth muscle cells appear between the endothelial cells and the internal elastic lamina of the aorta and a number of large conduit arteries (for review see Stary et all). In some arteries. such as the origin of the left coronary artery and the ductus arteriosus, the subendothelial smooth muscle cells are already present at the time of birth. Most of the intimal smooth muscle cells lie in a longitudinal direction. in contrast to their normal circular orientation in the media. with collagen and elastin fibers in between them. In this way. thickening of the intima is formed. The intimal thickening may be concentric (diffuse) or eccentric (focal). the so-called intimal cushions.
The intimal thickening is considered a physiological adaption to wall stress. 1 The closure of the ductus arteriosus is a process that is totally reliant upon physiological intimal thickening." The ductus arteriosus is a muscular artery that connects the pulmonary trunk and the aorta during fetal life and closes shortly after birth. In the normal ductus arteriosus. intimal thickening starts during the second trimester of pregnancy. 2 At the onset of this process, lifting of endothelial cells from the internal elastic lamina occurs.' with accumulation of hyaluronan in the subendothelial region" and fragmentation of the internal elastic lamina.' Thereafter. smooth muscle cells migrate into the subendothelial region.
Pathological intimal thickening
The physiological intimal cushions mark sites of predilection for atherosclerosis. where the lesions develop more rapidly than elsewhere. and where. therefore. symptomatic lesions tend to occur (for review see Stary et all). The introduction of PTCA, which is now a well-established treatment for coronary artery disease, greatly boosted scientific interest in intimal thickening due to the fact that restenosis remains an unresolved problem following this intervention. Restenosis is a time related phenomenon. which may lead to a new significant lumen reduction after coronary angioplasty in about 30-50% of patients within 6 months post-angioplasty.
Three independent processes contribute to the lumen reduction, which often occurs after a successful PTCA procedure: elastic recoil, arterial remodeling and intimal thickening. Due to acute elastic recoil, part of the initial lumen gain is lost soon after the procedure. Subsequently, the balance between two slower processes of intimal hyperplasia and arterial remodeling determines the final size of the lumen after the PTCA procedure.S Arterial remodeling represents processes that change the total vessel area. defined as the area circumscribed by the external elastic lamina. The arterial remodeling may consist of actual constriction of the artery (constrictive or negative remodeling). as has been-described in some animal models. or of compensatory enlargement. as has been described in de novo atherosclerosis." This is accompanied by parallel changes of the area circumscribed by the internal elastic lamina and the lumen.
Intravascular stents may largely prevent lumen loss due to elastic recoil and constrictive remodeling. The magnitude of the intimal thickening, the third process, which compromises the lumen, depends on the extent of initial vessel injury during the angioplasty. Restenotic plaque growth is a wound healing response to traumatization of the vascular wall associated with the therapeutic intervention. Studies with animal models and analysis of human plaque tissue harvested at autopsy or by atherectomy, demonstrate that this wound healing reaction has a cascade-like course. Initially. different cell types such as thrornbocytes, endothelial cells. monocytes/macrophages and smooth muscle cells play a role. Later. smooth muscle cells are the predominant cells involved,"
Animal models of intimal thickening
In order to unravel the mechanisms of intimal thickening there is a need for appropriate animal models. The arteries Vascular Medicine 1997; 2: 179-189 of most small species never develop either diffuse intimal thickening or intimal cushions at all. or do so only slowly as the animal ages.' However. intimal thickening occurs in all arteries as a response to a variety of different injuries. Models of restenosis and neointima formation are reviewed by Jackson." They can be separated into two categories (Table I) .
(I) Those where a normal, intact artery is injured with techniques such as denudation of endothelial cells by the gentle passage of a balloon embolectomy catheter. the distension of the artery with a balloon angioplasty catheter. stent implantation, a rotating wire," electrical stimulation,'? compression (crush). I 1 by blowing a stream of air through the artery,'? or by a perivascular collar.P"? These strategies may be combined with a high lipid diet. These types of injury can again be divided into two categories: (a) those that involve an intravascular technique and (b) those based on a perivascular method. The new intima that develops in response to injuries such as intravascular techniques. rigid polyethylene collars and electrical stimulation. is called 'neointima', since the original intima is damaged or removed. When there is no direct damage of the original intima, as is the case with a soft silicone collar, the response to this type of injury is called 'intimal thickening' (Table 1) . (2) Those where a second injury (balloon angioplasty) is performed on a primary lesion (Table I ). The term 'restenosis' is reserved for these vessels, in which there is already an underlying stenosis.
Neointima formation evoked by baBoon denudation of the rat carotid artery
The best-studied model of neointima formation is the response of the rat common carotid artery to balloon denudation injury.s.ls An important difference compared with clinical PTCA is that the gentle passage of the embolectomy cathether, unlike the repeated inflation of a slightly oversized balloon angioplasty catheter, does not create extensive tears or lacerations in the media. The rat carotid artery is selected because it is easily accessible via the external carotid artery and has a relatively long unbranched segment. Therefore, endothelial regrowth only occurs inward from the ends of the balloon-injured region. This model is useful to study the kinetics of smooth muscle cell response to injury and for the identification of molecules playing a role in the process of neointima formation in rats." Since endothelial cell removal with a fine wire evokes only a discrete. minimal intimal thickening," damage of the media appears important to provoke a regenerative lesion. Three phases can be identified in this neointima model: (I) medial smooth muscle cell replication (0-3 days after injury); (2) migration of smooth muscle cells across the internal elastic lamina to form the neointima 0-14 days after injury); and (3) replication of the neointimal cells (7 days to I month after injury). The neointima can be stimulated to show a further increase in replication by infusion of molecules including angiotensin II. bFGF (basic fibroblast growth factor). TGF-(3 (transforming growth factor (3),19-21 but not PDGF (platelet-derived growth factor)." 
Intimal thickening induced by a soft silicone collar
The positioning of a soft silicone collar around the carotid artery of rabbits induces intimal thickening within 2 weeks ( Figure I ). [13] [14] [15] [16] [17] The collar-induced intimal thickening Occurs with minimal medial smooth muscle cell damage." Focal patches of endothelial cells are lost during collar placement. In silicone collars, in contrast to rigid collars,23.24 the regrowth of these denuded areas is complete within 24 h. 25 In accordance with the rat carotid artery kinking of the carotid artery, inducing turbulence or changes in flow direction." changes in endothelial cells 14, 17.25 and the influx of leukocytes." By using collars from which the wall was partly removed it has been possible to discount hypoxia due to occlusion of vasa vasorum, inhibition of neuronal activity. kinking of the artery and changes in blood flow as major factors in the collar-induced initimal thickening." Based on this experimental evidence we proposed that the intimal thickening is the consequence of the combination of both discrete medial damage and hindrance of transmural flow by the collar. The obstruction of transmural fluid transport may then lead to retention of cytokines, growth factors and/or the development of hypoxia within the segment enclosed by the collar.
Time course of intimal thickening
Factors that enhance proliferation and/or migration of smooth muscle cells have been reviewed.P"-" and only the most important will be discussed here. In a review on neointima formation and intimal thickening, Jackson" pointed out that injury of the smooth muscle cells is a consistent feature. The injury may escape detection by light microscopy. but is illustrated by the abrupt and dramatic increase of smooth muscle cell proliferation, the first prerequisite for intimal thickening.
Mitogens of the first phase
The first phase of replication is due to the release of bFGF from dying smooth muscle cells. n . 33 Angiotensin II, endothelin. c-rnvc, and loss of growth inhibitors may also play a role in the control of medial replication.
Basic fibroblast growth factor
Basic libroblast growth factor (bFGF) may be involved in the development of stretch-induced smooth muscle cell proliferation. This factor is synthesized by both endothelial and smooth muscle cells and may be released from these cells foJlowing vascular injury." Basic FGF was found to be a potent stimulus of smooth muscle cell growth, especiaJly in the absence of an intact endothelium. 19 Angiotensin II The angiotensin converting enzyme (ACE) inhibitor cilazapril reduces neointima formation after balloon catheter injury of the rat carotid artery. It has an antiproliferative effect on medial smooth muscle ceJls and inhibits smooth muscle cell migration into the intima, but it only delays intimal extracellular matrix deposition. Therefore, the decrease in medial smooth muscle cell proliferation and subsequent migration seem to be the main reasons for the reduction in neointima formation." The effect of ACE inhibition on neointima formation after balloon denudation is associated with a reduction in early ceJlular events such as the expression of the proto-oncogenes c-fos and c-jun. This suggests that potent ACE inhibition at the time of vascular injury may be required to limit the hyperplastic response of the vessel wall." Similarly, blockade of the angiotensin II type 1 (AT!) receptor inhibits the induction of immediate-early genes tc-fos, c-jun, jun B, jun D, Egr-l) and fibronectin in rat balloon denudation injury. Thus, inhibition of neointima formation by AT 1 receptor blockade may be mediated at least in part by suppression of multiple genes related to ceJl growth and migration in the very early phase after vascular injury." There may be a temporal sequence for the response to injury in which fibroblast growth factor (FGF) induces ACE, ACE generates angiotensin II, and angiotensin II stimulates vascular smooth muscle cell growth in concert with FGF.38 Some of the effects of ACE inhibitors may be due to inhibition of bradykinin degradation (see section 'Loss of growth inhibitors' below). Furthermore, it is important to note that the doses of the ACE inhibitors that were effective in the rat failed to inhibit the intimal response in baboons," pigs 40 and rabbits."
Endothelins
There is also an increase in endothelin converting enzyme-I, endotheJin-l, and endothelin-3 and their receptor expression after baJloon angioplasty in the rat carotid artery, suggesting that these proteins may play an active role in the pathogenesis of neointima formation." Endothelin-I and angiotensin II may promote smooth muscle cell growth through common intracellular signaling mechanisms." c-myc The neointima formation after balloon injury of the rat carotid artery differs between the sexes and is estrogen dependent. Estrogen inhibits the response to injury in a mouse carotid artery model," protects against balloon injury in rabbit aorta and ileac arteries" and inhibits smooth muscle cell proliferation in the porcine left anterior descending coronary artery (for review see Foegh et aI 4 6 ) . Moreover, c-myc gene expression is greater in the undamaged carotid artery male than in that of the female, and the responsiveness of this gene to balloon injury of the artery is more rapid and more robust in the male than in the female." This is in agreement with the finding that transcatheter delivery of c-myc antisense oligomers reduces neointima formation in a porcine model of coronary artery balloon injury." Yascular Medicine 1997; 2: 179-189
Loss of growth inhibitors
Hitherto we discussed smooth muscle cell mitogens. However, neointima formation may also be due to the loss of growth inhibitors, such as heparin/heparan sulfate, transforming growth factor 13 or nitric oxide (NO) (for review see Scott-Burden and Vanhoutte'"), Repeated endothelial denudation augments neointima formation and acceleration of endothelial regeneration. The repeated endothelial regeneration results in progressively less production and/or release of NO. 50 NO can not only inhibit vascular smooth muscle cell proliferation't-" but also reversibly inhibits smooth muscle cell migration independently of proliferation or cytotoxicity.53.54 Moreover, NO plays a dual role in vascular cell proliferation, stimulating endothelial cells, but inhibiting smooth muscle cell proliferation. This dual effect of NO on cell proliferation is associated with an in vivo reduction in neointima formation after rat carotid artery injury and an acceleration of endothelial cell recovery both morphologically and functionally.ss Furthermore, the inhibition of neointima formation by ACE inhibitors in rat arteries may be a result of elevation of bradykinin.
Based on experiments with antagonists of bradykinin in combination with an inhibitor of NO synthase, it has indeed been suggested that the protective effect of ACE inhibitors is due to both blockade of angiotensin II formation and kinin degradation, and that NO may play a major role in the inhibitory effect of ACE inhibitors." Bradykinin is a potent stimulator of constitutive NO synthase in endothelial cells and is degraded by ACE. One problem with this explanation is the absence of endothelial cells in the denuded segment.
In vivo endothelial NO synthase (eNOS) gene transfer in the vessel wall after balloon denudation of the rabbit carotid artery provided further evidence for the inhibition of smooth muscle cell accumulation by NO.s7 Transfection of the eNOS gene not only restored NO production and relaxations of the denuded artery. it also inhibited neointima formation at day 14 after balloon injury by 70%. This experiment provides direct evidence that NO is an endogenous inhibitor of intimal hyperplasia in vivo and suggests the possibility of eNOS transfection as a potential therapeutic approach to treat restenosis after balloon angioplasty. Since smooth muscle cell mitosis was influenced less than intimal thickening after eNOS gene transfer" or treatment with an NO donor," inhibition of smooth muscle cell migration could possibly explain the suppression of intimal thickening by NO. Whether this is of importance to restenosis after PTCA in the clinic remains to be determined, as ,smooth muscle cells are already present in the intima and migration of smooth muscle cells from media to intima may not be a major determinant in intimal hyperplasia (see below).
Furthermore, in vitro studies suggest that in the presence of bFGF, NO can stimulate DNA synthesis in rat aortic smooth muscle cells in primary culture, whereas NO evokes inhibition of DNA synthesis in the passaged smooth muscle cells." Therefore, the role of NO as an endogenous inhibitor of smooth muscle cells is not clear.
Migration factors
In the second phase, several factors may contribute to the migration of smooth muscle cells, including leukocytes, PDGF, transforming growth factor~, bFGF, angiotensin II and von Willebrand factor. The relative contributions of these different factors are not known (for review see Schwartz et al").
Leukocyte-induced migration
Myocytes injured by mechanical forces may attract neutrophils and macrophages, which secrete mitogens that induce smooth muscle cell proliferation. Leukocyte migration induced by adventitial implantation of endotoxin-soaked thread was associated with marked intimal proliferation. Treatment with dexamethasone inhibited the leukocyte influx and prevented intimal hyperplasia/" as in other models of intimal thickening." Recently, using monoclonal antibodies against adhesion molecules as more selective tools to inhibit the influx of leukocytes. it has indeed been demonstrated that mononuclear leukocytes," but not neutrophils,6M4 promote intimal thickening by stimulating smooth muscle cell migration.
Platelet-derived growth factor (PDGF)
In contrast to in vitro studies. the main effect of POOF in the rat carotid denudation model is on smooth muscle cell migration and not on proliferation.R.n.6~When activated by ligand binding, both PDGF receptor subtypes a (pDGF-Ra) and~(PDGF-R~) stimulate proliferation. In contrast. only activation of the PDGF-R~subtype stimulates migration, whereas ligand binding to the PDGF-Ra leads to inhibition of cell migration. This suggests that PDGF-Ro and PDGF-R~may play different roles in smooth muscle cell function and may be involved in different regulatory mechanisms during neointima forrnation.?" Smooth muscle cells in the balloon-injured vessel wall of the rat are heterogeneous with regard to PDGF-B expression. Subculture of these cells may give rise to cultures that are either positive or negative for PDGF-B expression. There is abundant expression of the PDGF receptor~-subunit by intimal smooth muscle cells, suggesting that PDGF-B synthesized by these cells may be involved in neointima formation via a paracrine or autocrine mechani sm." Platelet-derived growth factor BB-homodimer (PDGF-BB) is strongly implicated in neointima formation in vivo and is the most potent known chernoattractant for vascular smooth muscle cells in vitro. Tyrosine phosphorylation of the novel focal adhesion-associated protein tyrosine kinase, p 125 focal adhesion kinase (pI25FAK), is regulated by integrins and by several factors that alter actin cytoskeletal organization. Recent findings suggest that tyrosine phosphorylation of pl25FAK and other focal adhesion-associated proteins may be implicated in the chemotactic response of vascular smooth muscle cells to PDGF-BB (for review see Abedi and Zach ary 6H).
However, PDGF may act predominantly as a mitogen in species other than the rat. PDGF-B gene expression in porcine arteries promotes neointima formation by both proliferation and migration of smooth muscle cells followed by synthesis of extracellular matrix and therefore acts through several mechanisms to play a role in the pathogenesis of neointima formation in vivo.s" Administration of transforming growth factor-Bt (TGF-I3I) enhances neointima formation in rabbit arteries injured with a balloon catheter . 70 Vascular Medicine 1997; 2: 179-189
Lessons from neointima models 183 
I'On Willebrand factor (I'~n
Accumulations of vWf in the subendothelial region may also play a role in the migrat ion of smooth muscle cells. This hypothesis is supported by the finding that vWf accumulates in the intima after the positioning of a soft nonocclusive silicone collar around the rabbit carotid artery" in the early stage s of intimal thickening (Figure 2) . After 6 weeks. by which time intimal thickening has cea sed expanding, these accumulations of vWf had disappeared. Furthermore, after balloon angioplasty (Figure 3 ) and dur- ing the formation of intimal thickening in the human ductus arteriosus. accumulation of vWf underneath the endothelial cells have been observed." These findings suggest that vWf may be involved in the migration of the smooth muscle cells from the media to the intima . Moreover. vWf can bind to the aV~3 integrin receptor," which is involved in ductus arteriosus smooth muscle cell migration." Besides the possibility that vWf itself is involved in the migration of smooth muscle cells. it may also be that a chemotactic stimulus is given by an associated protein. In the processing of vWf. a propolypeptide is secreted that is chemotactic at least for neutrophils and macrophages.?"
Matrix metalloproteinases
Before smooth muscle cells can migrate from the media to the intima the extracellular matrix has to be partly degraded by proteolytic enzymes. Matrix metalloproteinases (MMPs) have been implicated as key mediators in the freeing of the smooth muscle cells from their extracellular matrix cage . 75 -78 In rabbits . balloon injury produces an initial fall in tissue type plasminogen activity (tPA) and a rise in urokinase plasminogen activator (uPA) activity . The tPA increases back to control levels by 7 days. while uPA falls to below control levels between 7 days and I month. This suggests a mechanism whereby acute injury suppresses tPA and upregulated uPA activity. with increased tPA activity acting as a marker for vessel repair.79
Mitogens of the third phase
In the third phase smooth muscle cells proliferate in the intima . There is no molecule that has definitively been identified as a mitogen in this phase . PDGF-A chain, TGF-. and the angiotensin II receptor-l (ATI) are overexpressed in the rat neointima.I'v" In the rat model, infused PDGF-B does not stimulate replication." Insulin-like growth-factor-I (lGF-l) is overexpressed in the media."
Smooth muscle cell death
When re-endothelialization is achieved after endothelial denudation of the rat aorta. the neointima shows an important decrease in cellularity. This phenomenon is accompanied by apoptosis of smooth muscle cells. The number of apoptotic smooth muscle cells becomes important 15 days after endothelial injury and reaches a maximum at 20 days. At 45 days the neointima is re-endothelialized and no more apoptotic smooth muscle cells are detected. These findings indicate that apoptosis is an important mechanism in the regulation of neointima evolution. 82
Mural thrombus and neointima fonnation
The presence of angiographically identifiable thrombus at the time of angioplasty is associated with higher restenosis . The mechani sm by which this occurs is through vessel occlusion at follow-up angiography." Moreover. reduced acute thrombus formation results in decreased neointima formation after coronary angioplasty in minipigs.t" Mural fibrin(ogen) thrombus formation and incorporation contribute significantly to neointima formation after deep vascular injury of pig coronary arteries? or rabbit carotid arteries (Figure 4 ).85
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Lessons from animal models
Despite intensive research on neointima formation in the last two decades. an effective therapy for restenosis has not emerged to date. As illustrated in Table 2 , the vast majority of pharmacological strategies that decreased neointima formation in animal models, failed to reduce restenosis after PTCA in clinical trials . This suggests that most models of neointima formation poorly reflect the pathological processes leading to restenosis after PTCA. Several factors could explain this discrepancy. As pointed out earlier. acute elastic recoil and chronic constrictive remodeling contribute to lumen narrowing and could be more important than intimal thickening. So far. all pharmacological studies have been focused only on neointima format ion.
Constrictive remodeling
In animal models of restenosi s, neomtima formation is defined histologically. but normally lumen diameter is not. since this is subject to artifact s that occur as a consequence of histological preparation. In the clinic . lumen diameter is estimated by angiography. which may not be sensitive enough to detect changes in lumen area as a result of significant decreases in neointima formation." Furthermore. a chronic vasoconstrictor component. such as endothelin or loss of NO. may contribute to restenosis. Indeed. it has been reported that chronic recoil may account for more than 60% of the late lumen loss in restenosi s.'!" Therefore. both lumen area and wall thickne ss must be determined in vivo. Techniques such as magnetic resonance imaging and intravascular ultrasound used in both animal and clinical studies may improve the predictability of the models." Indeed. experimental results supported by histological and ultrasonographic data in man show that the wound healing 1. decrease; =, no effect.
Species
process that induces restenosis consists of constrictive remodeling. which decreases the perimeter of the external elastic lamina and the lumen. The use of stents appears to be the primary strategy to limit restenosis and prevent constrictive remodeling in man. even if it stimulates neointima formation. I 19.120 These stents can be coated with pharmacologically active agents.':" Understanding and controlling the remodeling process rather than concentrating solely on intimal hyperplasia may yield better results after balloon angioplasty in the future.JJ9.'2o.m In addition to the three processes that compromise the lumen physically, changes in the contractile behaviour of the dilated segment may predispose to vasospasm and recurrent angina. the clinical hallmark of restenosis, Changes of the functional dynamics of the artery are ignored in most studies of neointima formation, and could be as important as the anatomical loss of lumen.
Differences among arteries
Other important limitations of the neomtima models are related to differences between species and between anatomical sites. The arteries studied in small animals are generally the highly elastic carotid and iliac arteries. whereas human coronary arteries are more muscular. Moreover. the human arteries that develop atherosclerosis. and are thus !he. substrate for PTCA. always display a physiological intimal thickening. Pharmacological strategies that are directed towards either the inhibition of smooth muscle cell proliferation in the media. or the inhibition of the migration of smooth muscle cells from media to intima. may therefore not be of great relevance to the goal of reducing intimal thickening Vascular Medicine 1997; 2: 179-189 after balloon angioplasty in humans. This may explain why ACE inhibitors, which inhibit migration rather than proliferation of the smooth muscle cells in the intima. 8 • m suppress neointima formation evoked by denudation of the rat carotid artery, 112 but are not effective against restenosis after PTCA in human arteries. I 13 Presence of atherosclerotic plaques A further difference is that most experimental studies are performed in arteries that are either lesion-free, or contain relatively mild plaques, in contrast to complicated. stenotic lesions. which are the substrate for human PTCA. On the other hand. most human lesions are eccentric. and the PTCA balloon always exerts a large impact on the relatively normal arch of the arterial wall. depending on stiffness or compliance of the atherosclerotic plaque.
Grade of injury and thrombus formation
Another important difference among most experimental studies and restenosis after balloon angioplasty relates to the severity of the injury (Table 3 ). Indeed. it has been demonstrated that the degree of injury determines the degree of intimal proliferation'F'!" and the changes in vascular reactivity of the segment.':" The injury produced by denudation with a Fogarty balloon at low pressure and the mechanical forces to which the vessel is exposed are much lower than those produced by repeated high pressure inllation of a slightly oversized angioplasty balloon. Clinical angioplasty not only creates endothelial denudation. but also induces ruptures of the internal elastic membrane and deep medial tears often extending as far as adventitia.':"
The deep vascular injury and intramural haemorrhages +, present; -, absent. The discrepancy between the inhibition of neointima formation in the balloon-denuded rat carotid artery by various categories of drugs and the failure of those drugs to reduce the incidence of restenosis after PTCA in the clinic may lead to different conclusions. A first conclusion could be that the neointima in the denuded rat carotid artery is a model with limited similarities to intimal thickening evoked by balloon angioplasty in the clinic. Indeed. it is perhaps better to regard the neointima as the experimental equivalent of the physiological intimal cushions developing in atherosclerosis-prone human arteries. Another conclusion could be that intimal thickening is not a very significant factor in restenosis after PTCA in the clinic. Perhaps the most important conclusion is that it clearly indicates that alternative animal models need to be developed to screen more effectively for antirestenotic treatments. Further studies are required to validate whether the processes evoked by PTCA in the clinic are better mimicked by models. in which a more pronounced vascular injury is created by the inflation of a slightly oversized angioplasty balloon in arteries with or without primary atherosclerotic lesions. Nevertheless. balloon denudation remains a useful model to study mechanisms of intimal thickening. Recently. the in vivo application of the differential display technique in the rat carotid artery denudation model to identify mRNA transcripts whose expression is modulated selectively in vessels undergoing neointima formation has been described. 126 The use of this technique in other animal models of neointima formation should facilitate our understanding of gene expression patterns in the pathogenesis of intimal thickening. Also, gene transfer and the use of antisense oligonucleotides, which are segments of single stranded DNA that bind to the mRNA of the target, thereby inhibiting the expression of certain gene products, provide new therapeutic approaches to reduce neointima formation. Only the future will teach us whether these approaches will evolve to become clinically useful pharmacotherapies. evoked by balloon angioplasty in rabbits, swine and nonhuman primates immediately trigger mural thrombus formation as soon as blood flow is restored.I-" In contrast, after superficial injury (such as perivascular collar placement) intimal thickening is not associated with mural fibrin-rich thrombus incorporation, despite the presence of some early scarce transient medial fibrin(ogen) deposits."
Conclusion and perspectives
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The incorporation of the mural fibrin-rich thrombus contributes very significantly to neointima formation. Thrombin is not only involved in platelet aggregation and coagulation, but also triggers the release of growth factors and is also a potent vasoconstrictor. The formation of new mural thrombi and their incorporation into the neointima may persist for several weeks after the initial insult." Therefore, studies based on the superficial injury, like the frequently used balloon denudation model, may also give misleading information with respect to extent and roles of mural fibrinrich thrombi in balloon angioplasty in the clinic. Various antiplatelet and antithrombotic drugs have failed in human restenosis trials (Table 2) , despite success in animal models. This may be due to the fact that powerful anticoagulation is required when angioplasty is performed. In some clinical trials the treatment with oral anticoagulants was started too late. Moreover, the recurrent thrombus formation after balloon angioplasty of rabbit carotid arteries suggests that a more prolonged treatment with anticoagulants may be required. However, in a clinical study with C7E3. a monoclonal antibody against the platelet glycoprotein IIblIlIa receptor, restenosis was reduced (for review see Jackson" and Shaw et aI S6 ) . This may suggest that thrombus formation is a factor contributing to restenosis after PTCA in humans.
